Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 11, 1996

View Archived Issues

Pharma Mar describes cytotoxic xenicane diterpenes

Knoll claims potential anticonvulsants

LG Chemical describes novel vaccine adjuvant formulation

HMR describes NK1/NK2 antagonists for respiratory indications

Antitumor borneol esters reported by Schering AG

cGMP-PDE inhibitors revealed by Fujisawa

New neurotensin receptor ligands from Sanofi

New IGF-I variant disclosed by P&U

Allelix reports thrombospondin-derived antihemorrhagic peptide

Alliance Pharmaceutical: Annual Report 1996

Antithrombin III advances to phase II

Positive results of fomivirsen in the treatment of CMV retinitis

Cholesterol-lowering statin approved in first markets

DepoTech files IND for DepoMorphine

Medarex to acquire Houston Biotechnology

Warfarin underused for stroke prevention

EntreMed in-licenses angiogenesis inhibitor

FDA gives go-ahead to Hemagen for lupus diagnostic

Signal acquires rights to novel signaling proteins

Positive IDEC-C2B8 phase III trial results announced

Genset announces prostate cancer program discoveries

Milestone reached in Cubist/BMS antiinfective drug collaboration

Scotia drug shows excellent activity in cancer patients with cachexia